Save time and get answers to complex questions with AI chat
Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?Patent expiration eu dabrafenib?Is guselkumab off patent in u s?Drugpatentwatch market analysis industry today?The expiration date of the key patent for guselkumab?
See the DrugPatentWatch profile for Fabhalta
It sounds like you mean Fabhalta (iptacopan). Here are the common and important side effects reported for it, plus what to watch for.
Because iptacopan affects the complement system (similar to other C5 blockers), there’s an increased risk of certain infections. Get medical care promptly if you have:
Also watch for:
Your clinician may monitor:
For drugs in this class, patients are often advised about vaccinations and sometimes infection prevention measures. If you’re not sure what you’ve had, ask your prescriber.
Other Questions About Fabhalta :